Directory
>
Samarth Kulkarni
Samarth Kulkarni
Research Scientist | Repare Therapeutics
United States
Samarth Kulkarni
Summary
Dr. Samarth Kulkarni is a seasoned executive in the biotechnology sector, currently serving as the CEO of CRISPR Therapeutics since 2017. With a robust background in strategy and operations, he has played a pivotal role in the advancement of innovative therapeutic technologies. His career began at McKinsey & Company, where he led initiatives in personalized medicine and immunotherapy, and co-led the biotech practice. Samarth's leadership extends to several boards, including Centessa Pharmaceuticals and Black Diamond Therapeutics, reflecting his influence in precision oncology. He holds a Ph.D. in Bioengineering and Nanotechnology from the University of Washington and a B.Tech from the Indian Institute of Technology. His research has contributed significantly to the fields of molecular diagnostics and biological drug delivery. A thought leader in the industry, he has authored numerous publications in prestigious scientific and business journals, showcasing his commitment to advancing healthcare through innovation.
Samarth Kulkarni
Work Experience
Board Member at
Centessa Pharmaceuticals
March 2021 - Present
Samarth Kulkarni
Education
Indian Institute of Technology, Kharagpur, B.Tech
University of Washington, Doctor of Philosophy - PhD
Frequently Asked Questions about Samarth Kulkarni
What is Samarth Kulkarni email address?
Samarth Kulkarni's primary email address is ****************@crisprtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Samarth Kulkarni work for?
Samarth Kulkarni is a Research Scientist at Repare Therapeutics.
Where Samarth Kulkarni graduated from?
Samarth Kulkarni holds a degree in null from Indian Institute of Technology, Kharagpur.
How can I directly contact Samarth Kulkarni?
To contact Samarth Kulkarni directly, you can use the email address ****************@crisprtx.com. Complete contact information is available upon registration with Muraena.
Is Samarth Kulkarni an immigrant?
Yes, Samarth Kulkarni is an immigrant and currently based in United States
Who is Samarth Kulkarni?
Dr. Samarth Kulkarni is a seasoned executive in the biotechnology sector, currently serving as the CEO of CRISPR Therapeutics since 2017. With a robust background in strategy and operations, he has played a pivotal role in the advancement of innovative therapeutic technologies. His career began at McKinsey & Company, where he led initiatives in personalized medicine and immunotherapy, and co-led the biotech practice. Samarth's leadership extends to several boards, including Centessa Pharmaceuticals and Black Diamond Therapeutics, reflecting his influence in precision oncology. He holds a Ph.D. in Bioengineering and Nanotechnology from the University of Washington and a B.Tech from the Indian Institute of Technology. His research has contributed significantly to the fields of molecular diagnostics and biological drug delivery. A thought leader in the industry, he has authored numerous publications in prestigious scientific and business journals, showcasing his commitment to advancing healthcare through innovation.
Samarth`s contact details
****************@crisprtx.com
*********@bdtherapeutics.com
****************@centessa.com